Moreover, a mutagenesis screening identified the proto-oncogene Ras-responsive element-binding protein 1 (RREB1) as a genetic driver in DLBCL, with an impact on proliferation and KRAS signaling regulation. The gene discussed is KRAS; the disease is diffuse large B-cell lymphoma.